Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-10T08:46:26.457Z Has data issue: false hasContentIssue false
  • English
  • Français

Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy

Published online by Cambridge University Press:  25 August 2009

Armen Kocharian ,
Reza Shabanian ,
Mohammad Rafiei-Khorgami ,
Abdolrazagh Kiani  and
Giv Heidari-Bateni
Armen Kocharian
Affiliation:
Department of Pediatric Cardiology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Reza Shabanian
Affiliation:
Department of Pediatric Cardiology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Rafiei-Khorgami
Affiliation:
Department of Pediatric Cardiology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Abdolrazagh Kiani
Affiliation:
Department of Pediatric Cardiology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Giv Heidari-Bateni*
Affiliation:
Department of Pediatric Cardiology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
*
Correspondence to: Giv Heidari-Bateni, MD/MPH, General Practitioner, Children’s Medical Center, 62 Gharib Street, 14194, Tehran, Iran. Tel: +98 2166507851; Fax: +98 21 66930024; E-mail: givhb@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

We aimed to determine the effect of supplementation with coenzyme Q10 on conventional therapy of children with cardiac failure due to idiopathic dilated cardiomyopathy. In a prospective, randomized, double-blinded, placebo-controlled trial, we randomized 38 patients younger than 18 years with idiopathic dilated cardiomyopathy to receive either coenzyme Q10, chosen for 17 patients, or placebo, administered in the remaining 21. Echocardiographic systolic and diastolic function parameters were determined for every patient at baseline, and after 6 months of supplementation. The index score for cardiac failure in children as established in New York was used for assessing the functional class of the patients. After 6 months supplementation, 10 patients randomized to receive coenzyme Q10 showed improvements in the grading of diastolic function, this being significantly more than that achieved by those randomized to the placebo group (p value = 0.011). The mean score for the index of cardiac failure index for those receiving coenzyme Q10 was also lower than the control group (p value = 0.024).

Our results, therefore, indicate that administration of coenzyme Q10 is useful in ameliorating cardiac failure in patients with idiopathic dilated cardiomyopathy through its significant effect on improving diastolic function.

Keywords

Ubiquinoneheart failurepediatric
Type
Original Article
Information
Cardiology in the Young , Volume 19 , Issue 5 , October 2009 , pp. 501 - 506
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Hadj, A, Pepe, S, Rosenfeldt, F. The clinical application of metabolic therapy for cardiovascular disease. Heart Lung Circ 2007; 16 (Suppl): S56–S64.CrossRefGoogle ScholarPubMed
2. Singh, U, Devaraj, S, Jialal, I. Coenzyme Q10 supplementation and heart failure. Nutr Rev 2007; 65: 286–293.CrossRefGoogle ScholarPubMed
3. Bhagavan, HN, Chopra, RK. Potential role of ubiquinone (coenzyme Q10) in pediatric cardiomyopathy. Clin Nutr 2005; 24: 331–338.CrossRefGoogle ScholarPubMed
4. Langsjoen, PH, Vadhanavikit, S, Folkers, K. Response of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme 10. Proc Natl Acad Sci 1985; 82: 4240–4244.CrossRefGoogle Scholar
5. Poggesi, L, Galanti, G, Comeglio, M, Toncelli, L, Vinci, M. Effect of coenzyme Q10 on left ventricular function in patients with dilative cardiomyopathy. Current Therapeutic Research 1991; 49: 878–886.Google Scholar
6. Permanetter, B, Rossy, W, Klein, G, Weingartner, F, Seidl, KF, Blomer, H. Ubiquinone (coenzyme q10) in the long-term treatment of idiopathic dilated cardiomyopathy. Eur Heart J 1992; 13: 1528–1533.CrossRefGoogle ScholarPubMed
7. Munkholm, H, Hansen, HHT, Rasmussen, K. Coenzyme Q10 treatment in serious heart failure. BioFactors 1999; 9: 285–289.CrossRefGoogle ScholarPubMed
8. Watson, PS, Scalia, GM, Galbraith, A, Burstow, DJ, Bett, N, Aroney, CN. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Card 1999; 33: 1549–1552.CrossRefGoogle ScholarPubMed
9. Keogh, A, Fenton, S, Leslie, C, et al. Randomized double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure. Heart Lung Circ 2003; 12: 135–141.CrossRefGoogle ScholarPubMed
10. Elshershari, H, Ozer, S, Ozkutlu, S, Ozme, S. Potential usefulness of coenzyme Q10 in the treatment of idiopathic dilated cardomyopathy in children. Int J Cardiol 2003; 88: 101–102.CrossRefGoogle ScholarPubMed
11. Soongswang, J, Sangtawesin, C, Durongpisitkul, K, et al. The effect of coenzyme Q10 on idiopathic chronic dilated cardiomyopathy in children. Pediatr Cardiol 2005; 26: 361–366.CrossRefGoogle ScholarPubMed
12. Richardson, P, McKenna, W, Bristow, M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996; 93: 841–842.Google ScholarPubMed
13. Connolly, D, Rutkowski, M, Auslender, M, Artman, M. The New York University Pediatric Heart Failure Index: A new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138: 644–648.CrossRefGoogle ScholarPubMed
14. O’Leary, PW. Pediatric diastology: use and limitations of Doppler echocardiography in the evaluation of ventricular diastolic function in children. Prog Pediatr Cardiol 1999; 10: 83–93.CrossRefGoogle Scholar
15. O’Leary, PW, Durongpisitkul, K, Cordes, TM, et al. Diastolic ventricular function in children: a Doppler echocardiographic study establishing normal values and predictors of increased ventricular end-diastolic pressure. Mayo Clin Proc 1998; 73: 616–628.Google ScholarPubMed
16. Tei, C, Ling, LH, Hodge, DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function – a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26: 357–366.Google ScholarPubMed
17. Colan, SD, Parness, IA, Spevak, PJ, Sanders, SP. Developmental modulation of myocardial mechanics: age and growth-related alterations in afterload and contractility. J Am Coll Cardiol 1992; 19: 619–629.CrossRefGoogle ScholarPubMed
18. Tissières, P, Aggoun, Y, Da Cruz, E, et al. Comparison of classifications for heart failure in children undergoing valvular surgery. J Pediatr 2006; 149: 210–215.CrossRefGoogle ScholarPubMed
19. Little, WC, Cheng, C-P. Diastolic dysfunction. Cardiol Rev 1998; 6: 231–239.CrossRefGoogle ScholarPubMed
20. Vivekananthan, K, Kalapura, T, Mehra, M, et al. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Am J Cardiol 2002; 90: 517–520.CrossRefGoogle ScholarPubMed
21. Peltier, M, Slama, M, Garbi, S, Enriquez-Sarano, ML, Goissen, T, Tribouilloy, CM. Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction. Am J Cardiol 2002; 90: 1261–1263.CrossRefGoogle ScholarPubMed
22. Redfield, MM, Jacobsen, SJ, JrBurnett, JC, Mahoney, DW, Bailey, KR, Rodeheffer, RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194–202.CrossRefGoogle ScholarPubMed
23. Fischer, M, Baessler, A, Hense, HW, et al. Prevalence of left ventricular diastolic dysfunction in the community: results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003; 24: 320–328.CrossRefGoogle ScholarPubMed
24. Zile, MR, Brutsaert, DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002; 105: 1503–1508.CrossRefGoogle ScholarPubMed
25. Auslender, M. Pathophysiology of pediatric heart failure. Prog Pediatr Cardiol 2002; 11: 175–184.CrossRefGoogle Scholar
26. Bhagavan, HN, Chopra, RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006; 40: 445–453.CrossRefGoogle ScholarPubMed
27. Silver, MA, Langsjoen, PH, Szabo, S, Patil, H, Zelinger, A. Effect of Atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. Am J Cardiol 2004; 94: 1306–1310.CrossRefGoogle ScholarPubMed
28. Langsjoen, PH, Langsjoen, PH, Folkers, K. Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment. Clin Invest 1993; 71 (Suppl): S140–S144.CrossRefGoogle ScholarPubMed
29. Oda, T. Recovery of load-induced left ventricular diastolic dysfunction by coenzyme Q10: echocardiographic study. Mol Aspects Med 1994; 15 (Suppl): S149–S154.CrossRefGoogle ScholarPubMed
30. Lönnrot, K, Pörsti, I, Alho, H, Wu, X, Hervonen, A, Tolvanen, JP. Control of arterial tone after long-term coenzyme Q10 supplementation in senescent rats. Br J Pharmacol 1998; 124: 1500–1506.CrossRefGoogle ScholarPubMed
31. Belardinelli, R, Tiano, L, Littarru, GP. Oxidative stress, endothelial function and coenzyme Q10. Biofactors 2008; 32: 129–133.CrossRefGoogle ScholarPubMed
32. Tiano, L, Belardinelli, R, Carnevali, P, Principi, F, Seddaiu, G, Littarru, GP. Effect of coenzyme Q10 administration on endothelial function and extracellular superoxide dismutase in patients with ischaemic heart disease: a double-blind, randomized controlled study. Eur Heart J 2007; 28: 2249–2255.CrossRefGoogle ScholarPubMed
33. Grodecki, PV, Klein, AL. Pitfalls in the echo-Doppler assessment of diastolic dysfunction. Echocardiography 1993; 10: 213–234.CrossRefGoogle ScholarPubMed